Sanofi Boosts Consumer drugs Portfolio With Chattem Buy - Wall Street Journal
Globe and MailSanofi Boosts Consumer drugs Portfolio With Chattem BuyWall Street JournalFR) Monday stepped up its move into consumer drugs by entering the US market, acquiring Chattem Inc. (CHTT) for $1.9 billion. ...Sanofi stops development of two drugsReutersWhy Drug Companies Want to Sell Foot PowderWall Street Journal (blog)Sanofi ends development of insomnia, clot drugsBusinessWeekPharma Times�-The Associated Pressall 477 news articles��
Blog Content
No comments:
Post a Comment